1. Fu, Yadong, Zhou, Xiaoxi, Wang, Lin, Sun, Bing, Liu, Ping. 2024. Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. In Redox biology, 69, 103029. doi:10.1016/j.redox.2024.103029. https://pubmed.ncbi.nlm.nih.gov/38184998/
2. Fan, Weiguo, Liu, Tianhui, Chen, Wen, Jia, Jidong, Sun, Bing. 2019. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice. In Gastroenterology, 157, 1352-1367.e13. doi:10.1053/j.gastro.2019.07.036. https://pubmed.ncbi.nlm.nih.gov/31362006/
3. Zhang, Yaguang, Li, Xuezhen, Luo, Zhongguang, Liu, Jie, Sun, Bing. 2020. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation. In Proceedings of the National Academy of Sciences of the United States of America, 117, 3083-3092. doi:10.1073/pnas.1912774117. https://pubmed.ncbi.nlm.nih.gov/31980528/
4. Utsunomiya, Natsuko, Utsunomiya, Akira, Chino, Takenao, Hasegawa, Minoru, Oyama, Noritaka. 2020. Gene silencing of extracellular matrix protein 1 (ECM1) results in phenotypic alterations of dermal fibroblasts reminiscent of clinical features of lichen sclerosus. In Journal of dermatological science, 100, 99-109. doi:10.1016/j.jdermsci.2020.06.010. https://pubmed.ncbi.nlm.nih.gov/33046330/
5. Link, Frederik, Li, Yujia, Zhao, Jieling, Dooley, Steven, Wang, Sai. 2025. ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation. In Gut, 74, 424-439. doi:10.1136/gutjnl-2024-333213. https://pubmed.ncbi.nlm.nih.gov/39448254/
智鼠故事 
